- Home
- GNK vs GHRS Comparison
GNK vs GHRS Comparison
Compare GNK & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNK
- GHRS
- Stock Information
- Founded
- GNK 2004
- GHRS 2018
- Country
- GNK United States
- GHRS Ireland
- Employees
- GNK N/A
- GHRS N/A
- Industry
- GNK Marine Transportation
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- GNK Consumer Discretionary
- GHRS Health Care
- Exchange
- GNK Nasdaq
- GHRS Nasdaq
- Market Cap
- GNK 732.0M
- GHRS 774.1M
- IPO Year
- GNK 2005
- GHRS 2021
- Fundamental
- Price
- GNK $16.69
- GHRS $13.53
- Analyst Decision
- GNK Strong Buy
- GHRS Strong Buy
- Analyst Count
- GNK 1
- GHRS 9
- Target Price
- GNK $19.00
- GHRS $29.33
- AVG Volume (30 Days)
- GNK 453.7K
- GHRS 274.3K
- Earning Date
- GNK 11-05-2025
- GHRS 11-07-2025
- Dividend Yield
- GNK 8.73%
- GHRS N/A
- EPS Growth
- GNK 0.36
- GHRS N/A
- EPS
- GNK 0.36
- GHRS N/A
- Revenue
- GNK $350,742,000.00
- GHRS N/A
- Revenue This Year
- GNK N/A
- GHRS N/A
- Revenue Next Year
- GNK $20.29
- GHRS N/A
- P/E Ratio
- GNK $47.04
- GHRS N/A
- Revenue Growth
- GNK N/A
- GHRS N/A
- 52 Week Low
- GNK $11.20
- GHRS $6.72
- 52 Week High
- GNK $19.60
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- GNK 51.75
- GHRS 50.01
- Support Level
- GNK $16.35
- GHRS $12.50
- Resistance Level
- GNK $17.24
- GHRS $14.44
- Average True Range (ATR)
- GNK 0.38
- GHRS 1.04
- MACD
- GNK 0.12
- GHRS 0.01
- Stochastic Oscillator
- GNK 70.83
- GHRS 45.24
About GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.